2024-01-012024-12-312024-12-31false14058043THE EDGE HEALTH (BURY) LIMITED2025-09-1696040falseiso4217:GBPxbrli:pure140580432023-12-31140580432024-12-31140580432024-01-012024-12-31140580432022-12-31140580432023-12-31140580432023-01-012023-12-3114058043bus:SmallEntities2024-01-012024-12-3114058043bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3114058043bus:AbridgedAccounts2024-01-012024-12-3114058043bus:PrivateLimitedCompanyLtd2024-01-012024-12-3114058043core:WithinOneYear2024-12-3114058043core:AfterOneYear2024-12-3114058043core:WithinOneYear2023-12-3114058043core:AfterOneYear2023-12-311405804312024-01-012024-12-3114058043core:ShareCapital2024-12-3114058043core:SharePremium2024-12-3114058043core:RevaluationReserve2024-12-3114058043core:OtherReservesSubtotal2024-12-3114058043core:RetainedEarningsAccumulatedLosses2024-12-3114058043core:ShareCapital2023-12-3114058043core:SharePremium2023-12-3114058043core:RevaluationReserve2023-12-3114058043core:OtherReservesSubtotal2023-12-3114058043core:RetainedEarningsAccumulatedLosses2023-12-3114058043core:LandBuildings2024-12-3114058043core:PlantMachinery2024-12-3114058043core:Vehicles2024-12-3114058043core:FurnitureFittings2024-12-3114058043core:OfficeEquipment2024-12-3114058043core:NetGoodwill2024-12-3114058043core:IntangibleAssetsOtherThanGoodwill2024-12-3114058043core:ListedExchangeTraded2024-12-3114058043core:UnlistedNon-exchangeTraded2024-12-3114058043core:LandBuildings2023-12-3114058043core:PlantMachinery2023-12-3114058043core:Vehicles2023-12-3114058043core:FurnitureFittings2023-12-3114058043core:OfficeEquipment2023-12-3114058043core:NetGoodwill2023-12-3114058043core:IntangibleAssetsOtherThanGoodwill2023-12-3114058043core:ListedExchangeTraded2023-12-3114058043core:UnlistedNon-exchangeTraded2023-12-3114058043core:LandBuildings2024-01-012024-12-3114058043core:PlantMachinery2024-01-012024-12-3114058043core:Vehicles2024-01-012024-12-3114058043core:FurnitureFittings2024-01-012024-12-3114058043core:OfficeEquipment2024-01-012024-12-3114058043core:NetGoodwill2024-01-012024-12-3114058043core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3114058043core:ListedExchangeTraded2024-01-012024-12-3114058043core:UnlistedNon-exchangeTraded2024-01-012024-12-3114058043core:MoreThanFiveYears2024-01-012024-12-3114058043core:Non-currentFinancialInstruments2024-12-3114058043core:Non-currentFinancialInstruments2023-12-3114058043dpl:CostSales2024-01-012024-12-3114058043dpl:DistributionCosts2024-01-012024-12-3114058043core:LandBuildings2024-01-012024-12-3114058043core:PlantMachinery2024-01-012024-12-3114058043core:Vehicles2024-01-012024-12-3114058043core:FurnitureFittings2024-01-012024-12-3114058043core:OfficeEquipment2024-01-012024-12-3114058043dpl:AdministrativeExpenses2024-01-012024-12-3114058043core:NetGoodwill2024-01-012024-12-3114058043core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3114058043dpl:GroupUndertakings2024-01-012024-12-3114058043dpl:ParticipatingInterests2024-01-012024-12-3114058043dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3114058043core:ListedExchangeTraded2024-01-012024-12-3114058043dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3114058043core:UnlistedNon-exchangeTraded2024-01-012024-12-3114058043dpl:CostSales2023-01-012023-12-3114058043dpl:DistributionCosts2023-01-012023-12-3114058043core:LandBuildings2023-01-012023-12-3114058043core:PlantMachinery2023-01-012023-12-3114058043core:Vehicles2023-01-012023-12-3114058043core:FurnitureFittings2023-01-012023-12-3114058043core:OfficeEquipment2023-01-012023-12-3114058043dpl:AdministrativeExpenses2023-01-012023-12-3114058043core:NetGoodwill2023-01-012023-12-3114058043core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3114058043dpl:GroupUndertakings2023-01-012023-12-3114058043dpl:ParticipatingInterests2023-01-012023-12-3114058043dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3114058043core:ListedExchangeTraded2023-01-012023-12-3114058043dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3114058043core:UnlistedNon-exchangeTraded2023-01-012023-12-3114058043core:NetGoodwill2024-12-3114058043core:IntangibleAssetsOtherThanGoodwill2024-12-3114058043core:LandBuildings2024-12-3114058043core:PlantMachinery2024-12-3114058043core:Vehicles2024-12-3114058043core:FurnitureFittings2024-12-3114058043core:OfficeEquipment2024-12-3114058043core:AfterOneYear2024-12-3114058043core:WithinOneYear2024-12-3114058043core:ListedExchangeTraded2024-12-3114058043core:UnlistedNon-exchangeTraded2024-12-3114058043core:ShareCapital2024-12-3114058043core:SharePremium2024-12-3114058043core:RevaluationReserve2024-12-3114058043core:OtherReservesSubtotal2024-12-3114058043core:RetainedEarningsAccumulatedLosses2024-12-3114058043core:NetGoodwill2023-12-3114058043core:IntangibleAssetsOtherThanGoodwill2023-12-3114058043core:LandBuildings2023-12-3114058043core:PlantMachinery2023-12-3114058043core:Vehicles2023-12-3114058043core:FurnitureFittings2023-12-3114058043core:OfficeEquipment2023-12-3114058043core:AfterOneYear2023-12-3114058043core:WithinOneYear2023-12-3114058043core:ListedExchangeTraded2023-12-3114058043core:UnlistedNon-exchangeTraded2023-12-3114058043core:ShareCapital2023-12-3114058043core:SharePremium2023-12-3114058043core:RevaluationReserve2023-12-3114058043core:OtherReservesSubtotal2023-12-3114058043core:RetainedEarningsAccumulatedLosses2023-12-3114058043core:NetGoodwill2022-12-3114058043core:IntangibleAssetsOtherThanGoodwill2022-12-3114058043core:LandBuildings2022-12-3114058043core:PlantMachinery2022-12-3114058043core:Vehicles2022-12-3114058043core:FurnitureFittings2022-12-3114058043core:OfficeEquipment2022-12-3114058043core:AfterOneYear2022-12-3114058043core:WithinOneYear2022-12-3114058043core:ListedExchangeTraded2022-12-3114058043core:UnlistedNon-exchangeTraded2022-12-3114058043core:ShareCapital2022-12-3114058043core:SharePremium2022-12-3114058043core:RevaluationReserve2022-12-3114058043core:OtherReservesSubtotal2022-12-3114058043core:RetainedEarningsAccumulatedLosses2022-12-3114058043core:AfterOneYear2024-01-012024-12-3114058043core:WithinOneYear2024-01-012024-12-3114058043core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3114058043core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3114058043core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3114058043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3114058043core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3114058043core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3114058043core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3114058043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3114058043core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3114058043core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3114058043core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3114058043core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3114058043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3114058043core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3114058043core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3114058043core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3114058043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3114058043core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3114058043core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3114058043core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3114058043core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3114058043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3114058043core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3114058043core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3114058043core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3114058043core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3114058043core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3114058043bus:Director12024-01-012024-12-31

THE EDGE HEALTH (BURY) LIMITED

(formerly THE EDGE PERFORMANCE (BURY) LIMITED)

Registered Number
14058043
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

THE EDGE HEALTH (BURY) LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Director

CLARKE, Caryn Elizabeth

Registered Address

Community House
Badger Street
Bury
BL9 6AD

Registered Number

14058043 (England and Wales)
THE EDGE HEALTH (BURY) LIMITED
Statement of Financial Position
31 December 2024

Notes

2024

2023

£

£

£

£

Current assets
Cash at bank and on hand497364
497364
Creditors amounts falling due within one year3-(1,039)
Net current assets (liabilities)497(675)
Total assets less current liabilities497(675)
Creditors amounts falling due after one year4(39,008)(25,972)
Net assets(38,511)(26,647)
Capital and reserves
Profit and loss account(38,511)(26,647)
Shareholders' funds(38,511)(26,647)
The financial statements were approved and authorised for issue by the Director on 16 September 2025, and are signed on its behalf by:
CLARKE, Caryn Elizabeth
Director
Registered Company No. 14058043
THE EDGE HEALTH (BURY) LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

20242023
Average number of employees during the year01
3.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables-578
Taxation and social security-461
Total-1,039
4.Creditors: amounts due after one year

2024

2023

££
Other creditors39,00825,972
Total39,00825,972